Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 18

Results For "tele"

245 News Found

BSV to set up vaccine manufacturing facility in Genome Valley
News | April 13, 2022

BSV to set up vaccine manufacturing facility in Genome Valley

The total investment is in the region of Rs 200 crore


Dr. Morepen launches advanced muscle food
Healthcare | April 12, 2022

Dr. Morepen launches advanced muscle food

Ideal power boosters to strengthen muscles and keep energised for all kinds of physical activities


Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner
People | April 12, 2022

Healthcare Venture’s Wavemaker360 appoints Monica Jain as new partner

Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies


Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab
Biotech | April 11, 2022

Telix Pharmaceuticals announces licence agreement with Lilly for olaratumab

Lilly may be eligible for up to US $ 225m in payments based upon the achievement of pre-specified development, regulatory and commercial milestones


Clinical Trials in the New Normal
Opinion | March 24, 2022

Clinical Trials in the New Normal

The accelerated use of technology in clinical trials and the shift towards virtual trials is here to stay


IHL launches first zero assistance integrated health centre
Public Health | March 23, 2022

IHL launches first zero assistance integrated health centre

The first-of-its-kind unique centre will increase access to preventive & primary care


Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre
interviews | March 22, 2022

Venus Remedies aims to achieve Rs 1000 crore turnover by 2025: Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre

Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies and CEO, Venus Medicine Research Centre In conversation with Thomas C Thottathil, Editor, www.indianpharmapost.com identified key areas that the company is focusing on in its Mission 2025


Genomic data opened to researchers
Public Health | March 21, 2022

Genomic data opened to researchers

All of Us Research Program releases genomic data to researchers, combined with participant-generated data collected on Vibrent Health’s research platform


MFine launches heart rate monitoring tool on its App
Startup | March 04, 2022

MFine launches heart rate monitoring tool on its App

It plans launch various other health monitoring tools for smartphones, making existing devices obsolete


USFDA approves CITI Biopharma’s Vonjo
Drug Approval | March 01, 2022

USFDA approves CITI Biopharma’s Vonjo

Vonjo is the first approved therapy to specifically address the needs of adult cytopenic myelofibrosis patients